Total Voting Rights

RNS Number : 5731P
GlaxoSmithKline PLC
01 September 2017
 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 August 2017 consisted of 5,371,728,234 ordinary shares of 25 pence each ('Ordinary Shares'), of which 453,205,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,918,522,284. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

V A Whyte

Company Secretary

 

1 September 2017

 







 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUGUPCBUPMURG

Companies

GSK (GSK)
UK 100

Latest directors dealings